Barclays Maintains Overweight on Aptiv, Lowers Price Target to $60
Barclays analyst Dan Levy maintains Aptiv (NYSE:APTV) with a Overweight and lowers the price target from $65 to $60.
Share
Why It Matters
A big bank analyst still likes Aptiv but thinks the stock might be worth less money soon. You can watch if other experts agree or if the company's own plans change things.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.